Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment
Oncology Research · 2025
DOI: 10.32604/or.2025.067824 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Yi Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer…. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
- Department of Laboratory Animal Science, Kunming Medical University, Kunming, 650500, China.
- Department of Neurosurgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
- Department of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
- Department of Radiation Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
Zitieren
APA
Feng, Y., Yang, H., Liang, G., Chen, J., Li, T., Wang, Y., Chang, J., Li, Y., Yang, M., Zhou, X., Wang, Z., & Ge, C. (2025). Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. Oncology Research. https://doi.org/10.32604/or.2025.067824
Vancouver
Feng Y, Yang H, Liang G, Chen J, Li T, Wang Y, et al. Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. Oncology Research. 2025. doi:10.32604/or.2025.067824
BibTeX
@article{Feng2025,
author = {Feng, Yi and Yang, Haoxin and Liang, Guicai and Chen, Jun and Li, Tao and Wang, Yingjuan and Chang, Jilin and Li, Yan and Yang, Meng and Zhou, Xilong and Wang, Zhiqiang and Ge, Chunlei},
title = {Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.067824}
}
EUVIMED